NASDAQ · RETAIL-DRUG STORES AND PROPRIETARY STORES · SMALL CAP
Ridgetech, Inc. RDGT
6 fiscal years on record · USD · FY2024 reported
SEC FILINGS ONLY
Revenue · FY2024
$120.0M
▼ 3.2% vs FY2023
EPS · FY24
$1.84
Dividend / sh · FY24
—
Payout · FY24
—
ROE · FY24
45.0%
Net margin · FY24
8.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 120.0M
Revenue, FY2024 · full 6-year series below
Revenue
Net income
8 cents of every revenue dollar became profit this year.
Per share
USD 1.84
Diluted EPS, FY2024
EPS
The company pays no cash dividend.
Profitability
45.0%
Return on equity, FY2024
ROE
Operating margin-0.9%
Net margin8.5%
Return on assets12.8%
Each USD of equity produced 45 cents of profit this year.
Returned to shareholders
—
returned in FY2024 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+0.4% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−10.0%
+0.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.00B
Shares outstanding, FY2024
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 64.5M
total assets, end of FY2024
Total assetsUSD 64.5M
EquityUSD 29.6M
CashUSD 12.8M
Current ratio1.74×
Equity funds 46% of total assets.
History
6 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2024
2023
2022
2021
2020
2019
Revenue $B
0.1
0.1
0.1
0.2
0.1
0.1
Operating income $B
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
0.0
0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
−0.0
0.0
0.0
0.0
0.0
Net income $B
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
1.84
−2.93
−41.46
−18.35
−2.39
−2.16
Dividend / sh $
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
ROE %
45.0
−25.2
−100.4
−12.8
−31.5
·
Shares out B
0.00
0.00
0.00
0.00
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
22 of 22
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed